A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

September 15, 2022

Conditions
Hyperkalemia
Interventions
DRUG

Sodium Zirconium Cyclosilicate 5g

Suspension administered Sodium Zirconium Cyclosilicate 5g orally once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.

DRUG

Sodium Zirconium Cyclosilicate 10g

Suspension administered Sodium Zirconium Cyclosilicate 10g orally once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.

DRUG

Placebo

Suspension administered orally placebo once daily for 28 days after the open label initial phase with suspension administered Sodium Zirconium Cyclosilicate 10g orally three times per day for at most 2 days.

Trial Locations (66)

14010

Research Site, Baotou

100029

Research Site, Beijing

100144

Research Site, Beijing

100853

Research Site, Beijing

102206

Research Site, Beijing

110002

Research Site, New Delhi

110017

Research Site, New Delhi

116027

Research Site, Dalian

130021

Research Site, Changchun

132011

Research Site, Jilin

160030

Research Site, Chandigarh

200025

Research Site, Shanghai

200090

Research Site, Shanghai

200127

Research Site, Shanghai

214023

Research Site, Wuxi

215006

Research Site, Suzhou

225001

Research Site, Yangzhou

230022

Research Site, Hefei

230601

Research Site, Hefei

233004

Research Site, Bengbu

250021

Research Site, Jinan

266000

Research Site, Qingdao

300121

Research Site, Tianjin

300211

Research Site, Tianjin

310003

Research Site, Hangzhou

310009

Research Site, Hangzhou

315010

Research Site, Ningbo

330006

Research Site, Nanchang

350005

Research Site, Fuzhou

350025

Research Site, Fuzhou

361003

Research Site, Xiamen

380006

Research Site, Ahmedabad

380015

Research Site, Ahmedabad

380016

Research Site, Ahmedabad

410008

Research Site, Changsha

412007

Research Site, Zhuzhou

430030

Research Site, Wuhan

430033

Research Site, Changsha

430070

Research Site, Wuhan

434020

Research Site, Jingzhou

440012

Research Site, Nagpur

443003

Research Site, Yichang

500018

Research Site, Hyderabad

510080

Research Site, Guangzhou

510120

Research Site, Guangzhou

522002

Research Site, Vijayawada

523009

Research Site, Dongguan

524001

Research Site, Zhanjiang

550004

Research Site, Guiyang

560002

Research Site, Bangalore

560004

Research Site, Bangalore

Research Site, Bengaluru

570311

Research Site, Haikou

600001

Research Site, Chennai

610041

Research Site, Chengdu

610072

Research Site, Chengdu

650011

Research Site, Kunming

650021

Research Site, Kunming

700054

Research Site, Kolkata

710061

Research Site, Xi'an

730030

Research Site, Lanzhou

750004

Research Site, Yinchuan

810001

Research Site, Xining

810007

Research Site, Xining

030001

Research Site, Taiyuan

030012

Research Site, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY